Combined use of haemostatic system indices for evaluation of upper respiratory tract cancer progression

Aim: To analyze whether comprehensive assessment of haemostatic system components, in particular, indices of coagulation and fibrinolytic systems along with functionally related proteins, could be indicative of upper respiratory tract (URT) cancer progression. Materials and Methods: Indices of coagu...

Full description

Saved in:
Bibliographic Details
Published in:Experimental Oncology
Date:2016
Main Authors: Klys, Y.G., Gryn, N.V., Verevka, S.V.
Format: Article
Language:English
Published: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2016
Subjects:
Online Access:https://nasplib.isofts.kiev.ua/handle/123456789/137983
Tags: Add Tag
No Tags, Be the first to tag this record!
Journal Title:Digital Library of Periodicals of National Academy of Sciences of Ukraine
Cite this:Combined use of haemostatic system indices for evaluation of upper respiratory tract cancer progression / Y.G. Klys, N.V. Gryn, S.V. Verevka // Experimental Oncology. — 2016 — Т. 38, № 1. — С. 36–39. — Бібліогр.: 30 назв. — англ.

Institution

Digital Library of Periodicals of National Academy of Sciences of Ukraine
_version_ 1862558178138390528
author Klys, Y.G.
Gryn, N.V.
Verevka, S.V.
author_facet Klys, Y.G.
Gryn, N.V.
Verevka, S.V.
citation_txt Combined use of haemostatic system indices for evaluation of upper respiratory tract cancer progression / Y.G. Klys, N.V. Gryn, S.V. Verevka // Experimental Oncology. — 2016 — Т. 38, № 1. — С. 36–39. — Бібліогр.: 30 назв. — англ.
collection DSpace DC
container_title Experimental Oncology
description Aim: To analyze whether comprehensive assessment of haemostatic system components, in particular, indices of coagulation and fibrinolytic systems along with functionally related proteins, could be indicative of upper respiratory tract (URT) cancer progression. Materials and Methods: Indices of coagulation and fibrinolytic systems along with functionally related proteins, in particular, trypsinlike amidolytic activity, trypsin-like proteolytic activity, thrombin-like amidolytic activity, elastase-like amidolytic activity, fibrinolytic activity, potential amidolytic plasmin activity, content of fibrinogen, antithrombin III, α1-proteinase inhibitor, and α₂-macroglobulin, and prothrombin time were evaluated in blood plasma of patients with URT cancer of II (n = 10) and III (n = 25) stages with the use of routine biochemical methods. Results: For both groups of patients with URT cancer there have been shown notable differences for the majority of the studied indices, especially the indexes of proteolytic activities, from these of healthy donors, and in the case of URT cancer of III stage they reached statistical significance. In contrary, the changes in the content of antithrombin III, α₁-proteinase inhibitor, and α₂-macroglobulin were insignificant. In both groups of patients significant increase of fibrinogen content has been registered, while the content of soluble fibrinogen didn’t change. Also, in both groups of patients there a significant increase of potential activity of plasminogen was documented, while clot lysis time was significantly increased only in patients with III stage URT cancer. Multifactorial analysis of haemostatic system indices evidenced for efficacy of their combined use for evaluation of URT cancer progression risk. Conclusion: Combined use of fibrinogen and α₂-macroglobulin content and the level of amidolytic thrombinlike activity could serve as an indicator of URT cancer progression.
first_indexed 2025-11-25T22:46:41Z
format Article
fulltext
id nasplib_isofts_kiev_ua-123456789-137983
institution Digital Library of Periodicals of National Academy of Sciences of Ukraine
issn 1812-9269
language English
last_indexed 2025-11-25T22:46:41Z
publishDate 2016
publisher Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
record_format dspace
spelling Klys, Y.G.
Gryn, N.V.
Verevka, S.V.
2018-06-17T20:14:37Z
2018-06-17T20:14:37Z
2016
Combined use of haemostatic system indices for evaluation of upper respiratory tract cancer progression / Y.G. Klys, N.V. Gryn, S.V. Verevka // Experimental Oncology. — 2016 — Т. 38, № 1. — С. 36–39. — Бібліогр.: 30 назв. — англ.
1812-9269
https://nasplib.isofts.kiev.ua/handle/123456789/137983
Aim: To analyze whether comprehensive assessment of haemostatic system components, in particular, indices of coagulation and fibrinolytic systems along with functionally related proteins, could be indicative of upper respiratory tract (URT) cancer progression. Materials and Methods: Indices of coagulation and fibrinolytic systems along with functionally related proteins, in particular, trypsinlike amidolytic activity, trypsin-like proteolytic activity, thrombin-like amidolytic activity, elastase-like amidolytic activity, fibrinolytic activity, potential amidolytic plasmin activity, content of fibrinogen, antithrombin III, α1-proteinase inhibitor, and α₂-macroglobulin, and prothrombin time were evaluated in blood plasma of patients with URT cancer of II (n = 10) and III (n = 25) stages with the use of routine biochemical methods. Results: For both groups of patients with URT cancer there have been shown notable differences for the majority of the studied indices, especially the indexes of proteolytic activities, from these of healthy donors, and in the case of URT cancer of III stage they reached statistical significance. In contrary, the changes in the content of antithrombin III, α₁-proteinase inhibitor, and α₂-macroglobulin were insignificant. In both groups of patients significant increase of fibrinogen content has been registered, while the content of soluble fibrinogen didn’t change. Also, in both groups of patients there a significant increase of potential activity of plasminogen was documented, while clot lysis time was significantly increased only in patients with III stage URT cancer. Multifactorial analysis of haemostatic system indices evidenced for efficacy of their combined use for evaluation of URT cancer progression risk. Conclusion: Combined use of fibrinogen and α₂-macroglobulin content and the level of amidolytic thrombinlike activity could serve as an indicator of URT cancer progression.
en
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
Experimental Oncology
Original contributions
Combined use of haemostatic system indices for evaluation of upper respiratory tract cancer progression
Article
published earlier
spellingShingle Combined use of haemostatic system indices for evaluation of upper respiratory tract cancer progression
Klys, Y.G.
Gryn, N.V.
Verevka, S.V.
Original contributions
title Combined use of haemostatic system indices for evaluation of upper respiratory tract cancer progression
title_full Combined use of haemostatic system indices for evaluation of upper respiratory tract cancer progression
title_fullStr Combined use of haemostatic system indices for evaluation of upper respiratory tract cancer progression
title_full_unstemmed Combined use of haemostatic system indices for evaluation of upper respiratory tract cancer progression
title_short Combined use of haemostatic system indices for evaluation of upper respiratory tract cancer progression
title_sort combined use of haemostatic system indices for evaluation of upper respiratory tract cancer progression
topic Original contributions
topic_facet Original contributions
url https://nasplib.isofts.kiev.ua/handle/123456789/137983
work_keys_str_mv AT klysyg combineduseofhaemostaticsystemindicesforevaluationofupperrespiratorytractcancerprogression
AT grynnv combineduseofhaemostaticsystemindicesforevaluationofupperrespiratorytractcancerprogression
AT verevkasv combineduseofhaemostaticsystemindicesforevaluationofupperrespiratorytractcancerprogression